In this section you can read all the latest news about counterfeit and substandard medicines from around Europe and the world.
EVENT SUMMARY – Handling innovation in NANOMEDICINES: regulatory challenges and opportunities in modern healthcare
Event summary Handling Innovation in nanomedicines: regulatory changes needed to realise new treatment opportunities and ensure patient safety Science and technology have never moved as
Executive Summary Resources needed to implement the Falsified Medicines Directive in hospitals across the EU and the EEA would cost more than 86 million euros,
Invitation Breakfast Meeting – Handling innovation in NANOMEDICINES: regulatory challenges and opportunities in modern health
On behalf of the European Alliance for Access to Safe Medicines, we are delighted to invite you to a Breakfast Session on: Handling innovation in NANOMEDICINES:
Roundtable “Improving patient safety with the FMD in the hospital pharmacy, status of implementation” 19/02/19
The press release of the meeting can be found here. The edited version of the video of the meeting can be watched here. The manufacture and distribution of